EMAMI
|
EMAMI Last 5 Year Financial Ratios History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 18.48 | 16.58 | 14.50 | 19.02 | 10.23 |
| CEPS(Rs) | 22.47 | 20.85 | 19.83 | 26.55 | 18.48 |
| DPS(Rs) | 10.00 | 8.00 | 8.00 | 8.00 | 8.00 |
| Book NAV/Share(Rs) | 61.74 | 56.05 | 52.20 | 47.07 | 39.65 |
| Tax Rate(%) | 10.19 | 8.43 | 6.29 | -21.61 | 20.08 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 26.91 | 26.54 | 25.33 | 29.88 | 30.66 |
| EBIT Margin(%) | 23.71 | 22.38 | 19.88 | 21.75 | 20.21 |
| Pre Tax Margin(%) | 23.47 | 22.10 | 19.66 | 21.59 | 19.75 |
| PAT Margin (%) | 21.07 | 20.24 | 18.42 | 26.25 | 15.79 |
| Cash Profit Margin (%) | 25.75 | 25.43 | 25.68 | 36.75 | 28.52 |
| Performance Ratios | |||||
| ROA(%) | 27.44 | 25.92 | 22.73 | 31.61 | 17.49 |
| ROE(%) | 31.23 | 30.49 | 28.65 | 43.58 | 25.36 |
| ROCE(%) | 34.28 | 32.76 | 28.70 | 33.04 | 29.94 |
| Asset Turnover(x) | 1.30 | 1.28 | 1.23 | 1.20 | 1.11 |
| Sales/Fixed Asset(x) | 1.03 | 0.98 | 0.96 | 0.99 | 0.98 |
| Working Capital/Sales(x) | 3.99 | 5.43 | 6.05 | 20.30 | 6.75 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.97 | 1.02 | 1.05 | 1.01 | 1.02 |
| Receivable days | 45.30 | 46.35 | 39.41 | 31.65 | 34.20 |
| Inventory Days | 30.26 | 33.23 | 36.74 | 37.68 | 34.54 |
| Payable days | 136.04 | 135.51 | 123.94 | 129.16 | 132.60 |
| Valuation Parameters | |||||
| PER(x) | 31.37 | 25.88 | 24.72 | 23.55 | 47.67 |
| PCE(x) | 25.79 | 20.57 | 18.08 | 16.86 | 26.38 |
| Price/Book(x) | 9.39 | 7.65 | 6.87 | 9.51 | 12.30 |
| Yield(%) | 1.73 | 1.87 | 2.23 | 1.79 | 1.64 |
| EV/Net Sales(x) | 6.59 | 5.19 | 4.61 | 6.24 | 7.43 |
| EV/Core EBITDA(x) | 22.95 | 18.65 | 16.85 | 19.00 | 22.46 |
| EV/EBIT(x) | 27.78 | 23.21 | 23.19 | 28.72 | 36.77 |
| EV/CE(x) | 9.10 | 7.40 | 6.61 | 7.18 | 8.50 |
| M Cap / Sales | 6.64 | 5.23 | 4.64 | 6.20 | 7.53 |
| Growth Ratio | |||||
| Net Sales Growth(%) | 6.46 | 5.06 | 6.86 | 10.65 | 8.50 |
| Core EBITDA Growth(%) | 9.72 | 6.94 | -11.07 | 9.89 | 27.52 |
| EBIT Growth(%) | 12.79 | 18.30 | -2.33 | 19.05 | 47.55 |
| PAT Growth(%) | 10.86 | 15.42 | -25.01 | 84.00 | 50.41 |
| EPS Growth(%) | 11.46 | 14.33 | -23.77 | 85.92 | 53.03 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 0.02 | 0.03 | 0.03 | 0.13 | 0.05 |
| Current Ratio(x) | 2.22 | 1.87 | 1.78 | 1.17 | 1.61 |
| Quick Ratio(x) | 1.83 | 1.44 | 1.32 | 0.78 | 1.18 |
| Interest Cover(x) | 96.73 | 80.26 | 91.58 | 136.62 | 43.87 |
| Total Debt/Mcap(x) | - | - | - | 0.01 | - |
Compare Financial Ratios of peers of EMAMI
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| EMAMI | ₹23,782.7 Cr | 1.5% | -6% | -22.4% | Stock Analytics | |
| HINDUSTAN UNILEVER | ₹591,486.0 Cr | 1.5% | 1.1% | -4.5% | Stock Analytics | |
| GODREJ CONSUMER PRODUCTS | ₹115,682.0 Cr | 1.3% | -8% | -15.2% | Stock Analytics | |
| DABUR INDIA | ₹90,183.3 Cr | 2.2% | -2.1% | -11.4% | Stock Analytics | |
| COLGATEPALMOLIVE (INDIA) | ₹60,866.3 Cr | 0.2% | -2.3% | -33.5% | Stock Analytics | |
| PROCTER & GAMBLE HYGIENE AND HEALTH CARE | ₹44,042.4 Cr | -2.5% | 1.3% | -13.6% | Stock Analytics | |
EMAMI Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| EMAMI | 1.5% |
-6% |
-22.4% |
| SENSEX | 0.9% |
2.5% |
3.7% |
You may also like the below Video Courses
